Progress and Purpose
The midterm update of our 2019-2023 strategic plan describes accomplishments to date and identifies ongoing priorities.
Headlines
One Size Doesn’t Fit All: COVID-19 Vaccines and Immunocompromised Patients
We need more than our current one-size-fits-all approach to ensure adequate protection for people who don't mount a robust immune response.
An Update on Convalescent Plasma for COVID-19
Nearly two years into the pandemic, there's still debate on using convalescent plasma to treat COVID.
Will Biden’s Infrastructure Bill Address the Legacy of Racist Transportation Policies?
The bill has enormous potential to improve equity—if communities themselves have a say in how it’s implemented.
What Should Our COVID-19 Strategy Look Like in 2022?
Going into 2022, what should the next phase of our COVID strategy look like? Emily Gurley believes the focus should shift from avoiding infection to preventing hospitalizations and deaths.
Mouse Study Led by Bloomberg School Researchers Identifies Bacterial Protein Associated with Colorectal Cancers
The discovery raises the possibility that some of the roughly two million new cases of colorectal cancer every year around the world originate from brief and seemingly mild food-poisoning events.
Omicron Q&A: Making Some Sense of the Messiness of This Moment
Experts are learning more about the fast-moving omicron variant in real time. Here’s what we know right now.
Get the latest on COVID-19
Bridging Faith and Science to Combat the Overdose Crisis Series
On Tuesday, February 1, hear President Bill Clinton, Dr. Chinazo Cunningham, Patrick J. Kennedy, Rabbi Arthur Schneier, and other leaders, discuss how the faith and public health communities can take action on the overdose crisis.
Have a question about COVID-19 vaccines? Let's chat!
VIRA, a chatbot from Johns Hopkins, responds to questions about COVID-19 vaccines instantly—and confidentially.
Our Academic Program Offerings
Our programs welcome those from within and outside the traditional boundaries of public health. Whether you're a future college graduate, a midcareer public health leader, or someone looking to make a career change, we have a program for you.
We're cultivating a diverse, inclusive, and nurturing environment.
Our schoolwide Inclusion, Diversity, Anti-Racism, and Equity Action Plan identifies strategies for creating an anti-racist environment where we fuel our creativity and excellence by cultivating a more equitable, inclusive, and socially just community.
Meet Our Faculty
Our faculty are world-renowned experts, and trusted advisers to our students, public health leaders, and the public.
Aditi Sen
Aditi Sen, PhD, MA, is a health economist working to design and implement payment and delivery systems that improve quality of and access to care for all Americans.
Joel Gittelsohn
Joel Gittelsohn, PhD, MS, is a medical anthropologist and public health nutritionist who develops programs to improve food access and reduce risk for chronic diseases.
Christina Bethell
Christina Bethell, PhD, MPH, MBA, national leader in the development of policy, practice and research applications of population health and systems performance measurement.
Weiqiang Zhou
Weiqiang Zhou, PhD, develops statistical and computational tools for integrative analysis of large-scale genomic data to study gene regulation in cancer and immune system.
Why Choose the Johns Hopkins Bloomberg School of Public Health?
#1
Ranked by U.S. News & World Report since 1994
1st
and Largest School of Public Health
1,800+
Courses Offered
80+
Research Centers and Institutes
27K+
Alumni Living in over 160 Countries
90+
Degree Programs
40
Certificate Programs
5:1
Student-to-Primary-Faculty Ratio
Subscribe to Stay Informed
Support Our Work
Our work is made possible in part by contributions from Bloomberg School donors.